IP Library Granted Patent US 12,440,607
Granted Patent B2
US 12,440,607 · App. 17/811,115 · Granted Oct 14, 2025

Multifunctional crosslinkers: compounds, compositions, and products thereof

Inventor: Tyler Richard Long (Royersford, PA)
Assignee: BIOCOAT, INCORPORATED
A61L29/085A61L29/041A61L29/043A61L29/14C07C229/12C08K5/175C10M107/42C10M145/40A61L2400/10A61L2420/06C10M2209/12C10M2217/0285C10N2040/50C10N2050/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,440,607
App. No.
17/811,115
Granted
Oct 14, 2025
Kind
B2
Abstract

Multifunctional crosslinkers are a reaction product between a polyaziridine compound and two or more functionalized benzophenones. The polyaziridine compound is linked to the functionalized benzophenones through two or more reacted aziridine groups. Coating compositions, comprising: a polymer, and multifunctional crosslinkers. Coated medical devices, comprise a lubricious coating bonded adjacent to an exterior surface of the medical device. The lubricious coating is prepared by UV-curing a coating composition, wherein the coating composition comprises: a water/isopropyl alcohol (IPA) soluble polymer and/or a UV-curable polymer, and a water/IPA soluble multifunctional crosslinker.

Claims (8)

1. A multifunctional crosslinker comprising a reaction product between a polyaziridine compound and two or more functionalized benzophenones, wherein the polyaziridine compound is linked to the functionalized benzophenones through two or more reacted aziridine groups, wherein the polyaziridine compound is selected from: N,N′-(methylenedi-p-phenylene)bis(aziridine-1-carboxamide) (DAZ), trimethylolpropane bis(2-methyl-1-aziridine propionate), trimethylolpropane tris(2-methyl-1-aziridine propionate) (TMAZ), pentaerythritol bis(3-(1-aziridinyl) propionate, pentaerythritol tris(3-(1-aziridinyl) propionate (TAZ), pentaerythritol tetrakis(3-(1-aziridinyl) propionate, and combinations thereof.

2. The multifunctional crosslinker of claim 1 , wherein the polyaziridine compound comprises, two, three, or four aziridine functional groups.

3. The multifunctional crosslinker of claim 1 , wherein the compound comprises two, three, or four functionalized benzophenones each linked through a reacted aziridine group.

4. The multifunctional crosslinker of claim 1 , wherein the two or more functionalized benzophenones comprise a functionality selected from: a phenol group, a carboxylic acid group, a hydroxyl group, thiol group, amine group, and aniline group.

5. The multifunctional crosslinker of claim 1 , wherein the two or more functionalized benzophenones are selected from: 4-hydroxybenzophenone (HPB), 2,4-dihydroxybenzophenone (DHB), 2,2′,4,4′-tetrahydroxybenzophenone, 2,2′-dihydroxy-4-methoxybenzophenone, 2,3,4-trihydroxybenzophenone, 4,4′-dihydroxybenzophenone, 2,4,4′-trihydroxybenzophenone, 4′-hydroxy-2,4-dimethoxybenzophenone, 2-4-(dibutylamino)-2-hydroxybenzoylbenzoic acid, 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid, 2-(4-hydroxybenzoyl)benzoic acid, 4-benzoylbenzoic acid, 3-benzoylbenzoic acid, 2-benzoylbenzoic acid (BBA), 4-aminobenzophenone, 3-aminobenzophenone, 2-aminobenzophenone, 2-aminobenzophenone-2′-carboxylic acid, 4-benzoyl benzylamine hydrochloride, 4′-hydroxy-N,N-diethylaminobenzophenone, 4′-hydroxy-N,N-dimethylaminobenzophenone, 4′-hydroxy-N,N-dihydroxyethylaminobenzophenone thioxathone-2-carboxylic acid, 2-mercaptothioxanthone, and combinations thereof.

6. The multifunctional crosslinker of claim 1 , wherein the multifunctional crosslinker is HBP-TMAZ, BBA-TAZ, DHB-TMAZ, and combinations thereof.

7. The multifunctional crosslinker of claim 1 , wherein the multifunctional crosslinker generates free radicals upon exposure to ultraviolet radiation and crosslinks via hydrogen extraction.

8. The multifunctional crosslinker of claim 1 , wherein the multifunctional crosslinker is soluble in water or water/IPA at a weight ratio of between 5% and 95% by wt.

Assignments (10)
CHANGE OF NAME Recorded Mar 5, 2026
From: BIOCOAT, INCORPORATED
To: SURMODICSST, INCORPORATED
Reel/Frame 075046/0105 →
SECURITY INTEREST Recorded Feb 3, 2026
From: INTEGER HYDROPHILIC TECHNOLOGIES LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 073675/0456 →
CHANGE OF NAME Recorded Jan 12, 2026
From: INTEGER AUGUSTA TECHNOLOGIES LLC
To: INTEGER HYDROPHILIC TECHNOLOGIES LLC
Reel/Frame 074329/0875 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2026
From: BIOCOAT, INCORPORATED
To: INTEGER AUGUSTA TECHNOLOGIES LLC
Reel/Frame 073381/0915 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 061609/0774 Recorded Nov 23, 2025
From: BMO BANK N.A. (F/K/A BMO HARRIS BANK N.A.)
To: BIOCOAT, INCORPORATED
Reel/Frame 073768/0769 →
RELEASE OF SECURITY INTEREST RECORDED AT 061615/0577 Recorded Nov 23, 2025
From: ALTER DOMUS (US) LLC
To: BIOCOAT, INCORPORATED
Reel/Frame 073768/0342 →
SECURITY INTEREST Recorded Nov 1, 2022
From: BIOCOAT, INCORPORATED
To: BMO HARRIS BANK N.A., AS COLLATERAL AGENT
Reel/Frame 061609/0774 →
SECURITY INTEREST Recorded Nov 1, 2022
From: BIOCOAT, INCORPORATED
To: ALTER DOMUS (US) LLC
Reel/Frame 061615/0577 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 060577 FRAME: 0631. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 4, 2022
From: LONG, TYLER RICHARD
To: BIOCOAT, INCORPORATED
Reel/Frame 061686/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2022
From: LONG, TYLER RICHARD
To: BIOCOAT, INC.
Reel/Frame 060577/0631 →
Continuity (2)
Provisional Application 63221177 · Jul 13, 2021
Related Publication 20230027324A1 · Jan 26, 2023
References Cited (17)
US 20020037984A1 · Vanderbilt · 2002 [cited by applicant]
US 20070032882A1 · Lodhi et al. · 2007 [cited by applicant]
US 20070141365A1 · Jelle et al. · 2007 [cited by applicant]
US 20070286959A1 · Palmer · 2007 [cited by applicant]
US 20110063567A1 · Domschke et al. · 2011 [cited by applicant]
US 20110134387A1 · Samuel et al. · 2011 [cited by applicant]
US 20120178872A1 · Blanquer et al. · 2012 [cited by applicant]
US 20170281831A1 · Militello · 2017 [cited by applicant]
US 20210115349A1 · Long · 2021 [cited by examiner]
US 20210115350A1 · Long · 2021 [cited by examiner]
JP 576652A · 1982 [cited by applicant]
JP 576765A · 1982 [cited by applicant]
JP S5767651A · 1982 [cited by applicant]
JP S5767652A · 1982 [cited by applicant]
WO 2010129328A2 · 2010 [cited by applicant]
WO 2013109930A1 · 2013 [cited by applicant]
Mario Gleria, et al.; entitled “Oxazoline-containing phosphazene derivatives. Part I: the case of hexakis(4-oxazolinophenoxy)cyclophosphazene”; Designed Monomers And Polymers; vol. 4; No. 3; Jan. 1, 2001; pp. 219-238. [cited by applicant]